We are live on ! Find out more

53 hedge funds and large institutions have $2.42M invested in BioVie in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 6

0% more ownership

Funds ownership: 0.05%0.05% (+0%)

5% less funds holding

Funds holding: 5653 (-3)

23% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 13

59% less capital invested

Capital invested by funds: $5.95M → $2.42M (-$3.53M)

69% less call options, than puts

Call options by funds: $295K | Put options by funds: $952K

Holders
53
Holders Change
-3
Holders Change %
-5.36%
% of All Funds
0.77%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
21
Reduced
6
Closed
13
Calls
$295K
Puts
$952K
Net Calls
-$657K
Net Calls Change
+$1.25M

BIVI Hedge Fund Activity: Q4 2023 in Review

53 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q4 2023, worth a combined $2.42M — down 59% from $5.95M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of BIVI and 10 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 21 added.

The largest buyer was BlackRock, adding an estimated $838K. The largest seller was Ikarian Capital, exiting entirely with an estimated $1.56M sold.

  • 53 institutional investors held BioVie (BIVI) as of Q4 2023, down from 56 in Q3 2023.
  • Funds reported $2.42M of BioVie stock for Q4 2023, down 59% quarter-over-quarter.
  • 10 funds opened new BioVie positions in Q4 2023 and 13 closed out, a net change of -3 holders.
  • The largest BioVie buyer in Q4 2023 was BlackRock, an estimated $838K added.
  • The largest BioVie seller in Q4 2023 was Ikarian Capital, an estimated $1.56M sold.

Based on aggregated 13F filings for Q4 2023.